[Form 4] NEOGEN CORP Insider Trading Activity

Rhea-AI Filing Summary

Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.

Insights

Corporate Governance Analyst

Director RSU vesting shows alignment with shareholders through equity compensation.

The reported transaction documents the vesting and settlement of 2,071 RSUs into common shares on 10/07/2025, increasing the director's direct holdings to 14,852 shares. This is a standard compensation event where the RSUs convert to shares at the stated value.

Key dependencies include the company's equity award schedule and any trading-window or blackout restrictions that govern when shares can be sold. Near-term visibility: this is a settled award with no further conversion dates disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Ronald D

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/07/2025		M		2,071	A	$5.63	14,852	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$5.63	10/07/2025		M			2,071	10/07/2025	10/07/2025	Common Stock	2,071	$5.63	0	D

Explanation of Responses:

Remarks:

Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.

	Christopher Sefcheck (Attorney in Fact)	10/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Neogen (NEOG) report on Form 4 dated 10/07/2025?

The filing reports that director Ronald D. Green had 2,071 RSUs vest and be settled into 2,071 shares of common stock on 10/07/2025.

At what price were the RSUs settled for Neogen (NEOG)?

The RSUs were settled at an effective price of $5.63 per share.

How many shares does Ronald D. Green beneficially own after the transaction?

Following the settlement, Mr. Green directly owned 14,852 shares.

Was the Form 4 filed jointly or by one reporting person?

The Form 4 was filed by one reporting person (individual filing).

Does the Form 4 indicate any derivative transactions or future exercisable awards?

No. The filing shows the RSUs vested and were settled into common stock on the same date; there are no remaining derivative exercisable amounts disclosed.